ClinicalTrials.Veeva

Menu

Millet Products Study - Investigation of Glycemic Index and Satiety

U

University of Guelph

Status

Completed

Conditions

Hyperglycemia
Lack of Satiety

Treatments

Other: Commercial white bread
Other: Millet based products (porridge etc.)
Other: Corn based products (porridge etc.)

Study type

Interventional

Funder types

Other

Identifiers

NCT02075788
13AP004

Details and patient eligibility

About

The purpose of this study is to investigate how millet incorporation into different baked product types influences glycemic response and satiety.

Full description

The purpose of this study is to investigate how millet incorporation into different baked product types (i.e. an extruded snack versus a biscuit) influences glycemic response and satiety.

This project will examine the effect of millet, on glycemic response and satiety. To determine the effect of product matrix and processing methods, testing will be done using an extruded snack, porridge, a couscous-like product and a biscuit.

All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.

Enrollment

12 patients

Sex

Male

Ages

19 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Men, age 19-40, non-smoking
  • Normal fasting plasma glucose (<5.6 mmol/L but not below 3.6 mmol/L)
  • Normal glucose tolerance (evaluated by a 75 g oral glucose test, i.e. <7.8 mmol/L but not below 3.6 mmol/L)
  • BMI ranging from 18.5 to 29.9 kg/m2

Exclusion criteria

  • Insulin resistance (IR) will be calculated from fasting glucose and insulin values using the Homeostasis Assessment Model 2 (HOMA2). A HOMA2-IR value of greater than 1.0 will be considered indicative of insulin resistance (Levy J.C. et al. 1998).
  • Regular consumption of millet as defined by questionnaire at screening defined as more than 1x per week
  • Smoking or use of recreational drugs
  • Heavy alcohol use (defined as typically >14 drinks per week or >4 drinks on one occasion)
  • Very low fibre consumption as assessed by 24 hour food diary and self-reported fruit/vegetable/whole grain servings.
  • Restrained eater as defined by the questionnaire at screening (Three Factor Eating Questionnaire, Stunkard et al.,1985)
  • Food neophobic defined by Food Neophobia Scale questionnaire
  • Unusual sleep patterns or irregular breakfast consumption
  • Recent (i.e. >4 kg in previous 3 months) or intended weight loss or gain
  • Food allergies or any life-threatening allergy (food or otherwise)
  • Inflammatory bowel disease or other gastrointestinal disorders
  • Use of drugs which influence carbohydrate metabolism
  • Training or elite athletes
  • Inability to adhere to Study Protocols

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

12 participants in 3 patient groups, including a placebo group

Commercial white bread
Placebo Comparator group
Description:
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Treatment:
Other: Commercial white bread
Millet based products (porridge etc.)
Experimental group
Description:
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Treatment:
Other: Millet based products (porridge etc.)
Corn based products (porridge etc.)
Active Comparator group
Description:
All product servings will provide 50 g of available carbohydrate and will be consumed by participants within 10 minutes.
Treatment:
Other: Corn based products (porridge etc.)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems